ESMO Live Update | Dr. Girard Analyzes PAPILLON trial: Opening New Doors for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Advanced NSCLC
Based on the results of the PAPILLON trial, presented at Presidential Symposium 1 at the ESMO Congress 2023 (Madrid, Spain, 20-24 October), a dual-specificity EGFR/MET-directed monoclonal antibody has the potential…